Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease——balance of ef cacy and risk

HIGHLIGHTS

• who: January and colleagues from the University of California, Los Angeles, United States have published the research work: Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of ef cacy and risk, in the Journal: (JOURNAL) of 31/Dec/2019
• what: The authors aimed to deduce an efficacy-risk-balanced dose through a direct comparison of different dose categories in patients with HFpEF and CKD.
• how: The authors assessed the association of different eGFR categories and outcomes using the unadjusted Cox . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.